Medscape Medical News
- Alert Atezolizumab Now Also Approved for Front-Line NSCLC
- Alert Mylan Expands Recall to All Unexpired Lots of Valsartan in US
- Alert Three Common Dementia Screens Faulty, Inaccurate
- Alert FDA Warns About Serious Adverse Effect of AML Drug Enasidenib
- FDA Warns of Stroke, Dissection Risk With MS Drug Alemtuzumab
- Alert Unpleasant Surprises With Blood Pressure Drug for PTSD
- Drug Overdose, Suicide Deaths Cut US Life Expectancy
- Alert Neuronavigation System Recalled Due to Brain Damage Risk
- Alert Teva Recalls All Amlodipine/Valsartan Combination Products in US
- Alert FDA Warns of High Levels of Heavy Metals in Kratom
- Alert Mylan Recalls 15 Lots of Valsartan Products in US
- Alert FDA Warns of MS Worsening After Stopping Fingolimod (Gilenya)
- Alert EMA Curtails Use of Fluoroquinolone, Quinolone Antibiotics
- Alert Another Tainted 'Sartan' Recalled for Impurity
- Alert FDA Warns Against Using Unapproved Meds in Implanted Pain Pumps
- Alert Janssen Recalls Some Oral Contraceptives With Instruction Errors
- Alert FDA Panel Fails to Support Novel Opioid for Depression
- Alert FDA: Class I Recall of Roche Warfarin INR Test Strips
- Alert FDA Issues Alert on Irbesartan Due to Contamination
- Alert Common Household Chemicals Tied to Language Delays in Kids